Delamanid: a review of its use in patients with multidrug-resistant tuberculosis.
about
Antibiotics in the clinical pipeline at the end of 2015.Novel targeting of PEGylated liposomes for codelivery of TGF-β1 siRNA and four antitubercular drugs to human macrophages for the treatment of mycobacterial infection: a quantitative proteomic study.Delamanid susceptibility testing of Mycobacterium tuberculosis using the resazurin microtitre assay and the BACTEC™ MGIT™ 960 system.The anti-tubercular drug delamanid as a potential oral treatment for visceral leishmaniasisBedaquiline for the treatment of drug-resistant tuberculosis.Identification of an anti-TB compound targeting the tyrosyl-tRNA synthetase.Cholesterol metabolism: a potential therapeutic target in Mycobacteria.Type-II NADH Dehydrogenase (NDH-2): a promising therapeutic target for antitubercular and antibacterial drug discovery.News on therapeutic management of MDR-tuberculosis: a literature review.7th Union Europe Conference on Lung Health, 22-24 June 2016, Bratislava (Slovakia): a delegate report.Plasmid to generate Mycobacteria mutants.Delamanid and Bedaquiline Resistance in Mycobacterium tuberculosis Ancestral Beijing Genotype Causing Extensively Drug-Resistant Tuberculosis in a Tibetan Refugee.Delamanid, Bedaquiline, and Linezolid Minimum Inhibitory Concentration Distributions and Resistance-related Gene Mutations in Multidrug-resistant and Extensively Drug-resistant Tuberculosis in Korea
P2860
Q30249262-043F1280-0D7F-4803-B8BD-97D59709264EQ35950533-21E75193-D4A8-4471-81F8-551D25306A22Q35989196-C0772269-B849-41C3-BD1A-37BBE23501D0Q36932080-741164AB-5778-40CA-BAF2-64DBB25A3879Q38386950-96D6AC12-A32A-4620-B61B-5045E57DDBE9Q38877288-F06B3ABF-C841-4450-8832-C292FB268515Q39047211-8E27473B-A217-4023-B1E1-D875B31E6D32Q39284340-191F8F66-292E-43B7-AC74-B2CA43FE10C2Q39398924-027A36B0-60DA-4D76-841A-ECEA6AE54F22Q42398699-2D6112DD-624E-490E-8B3A-A2CC280716D0Q47697939-74879D3A-B6EF-45FE-A454-4F8D8A4DA15BQ53799340-BA027852-BEA0-46B7-BC11-FCCF99034FCEQ57212447-0012937A-A4B3-49A9-8106-FC72C4345E56
P2860
Delamanid: a review of its use in patients with multidrug-resistant tuberculosis.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Delamanid: a review of its use in patients with multidrug-resistant tuberculosis.
@ast
Delamanid: a review of its use in patients with multidrug-resistant tuberculosis.
@en
type
label
Delamanid: a review of its use in patients with multidrug-resistant tuberculosis.
@ast
Delamanid: a review of its use in patients with multidrug-resistant tuberculosis.
@en
prefLabel
Delamanid: a review of its use in patients with multidrug-resistant tuberculosis.
@ast
Delamanid: a review of its use in patients with multidrug-resistant tuberculosis.
@en
P2860
P1433
P1476
Delamanid: a review of its use in patients with multidrug-resistant tuberculosis.
@en
P2093
Hannah A Blair
P2860
P2888
P304
P356
10.1007/S40265-014-0331-4
P577
2015-01-01T00:00:00Z
P5875
P6179
1002551614